By: Timothy Hay From: wsj.com Nat Turner was working as a Google Inc. GOOGL +0.77% product manager when he learned that his seven-year-old cousin, Brennan, had been diagnosed with a rare form of leukemia. He observed the boy’s dad traveling all over the country interviewing different cancer specialists about his son’s case, all the while carrying stacks of DVDs and …
Cancer doctors’ triumphs, despair, heartbreak, joy
By: Ann Hardie From: ajc.com In 2012, Atlanta author Vincent Coppola was shocked and devastated when he joined 1.6 million other Americans diagnosed that year with cancer. Following the brutal treatment, the 66-year-old regained some semblance of normalcy by — what else? — writing a book about cancer, “The Big Casino.” The title refers to a euphemism coined by doctors …
Cancer research at a crossroads in Germany
From: euractiv.com A new EU regulation is meant to make clinical trials easier and more transparent, a pivotal tool in the fight against deadly diseases like cancer. But researchers in Germany warn that the country may lose its role as a leader in international medicine. EurActiv Germany reports. Clinical trials are crucial for cancer researche, as demonstrated by numbers which …
NATIONAL PINK DAY IS JUNE 23: WEAR PINK TO REMEMBER
National Pink Day is Monday, June 23. Because the color pink represents breast cancer, The Women’s Breast Health Initiative, Florida Affiliate (WBHI) would like to take this opportunity to raise breast cancer awareness. October may be Breast Cancer Awareness Month; however, breast cancer does not only strike in October. National Pink Day is the perfect time to remind all women …
Cancer test delays are putting lives at risk, experts warn
By: Denis Campbell From: theguardian.com Cancer patients’ chances of survival are being put at risk by growing delays in carrying out vital tests on them on the NHS, experts in the disease warn today. New official figures show that the number of people waiting more than six weeks for an MRI or CT scan has doubled in a year and …
Biotech Makes Personalized Cancer Vaccines Using Tumor Samples
By: Susan Young Rojahn From: technologyreview.com A highly personalized medical technique is allowing patients with advanced kidney cancer to live nearly three times as long as they normally do. In an experiment involving 21 patients, around half lived more than two and half years after diagnosis with kidney cancer that had begun to spread. Five patients are alive after more …
Trials let more patients get ‘breakthrough’ cancer therapies closer to home
By: Liv Osby From: greenvilleonline.com Rhonda McNeely will never forget that November day she had to tell her children she had advanced cancer. “When you have to come home and tell your daughters that you have cancer,” she said, “the looks in their eyes … it was a very sobering thing for all of us.” If there was any ray …
Prostate cancer drug delivers benefits before chemotherapy
An international clinical trial, led by the Knight Cancer Institute at Oregon Health & Science University, explored use of enzalutamide before chemotherapy; the drug reduced the risk of disease progression by 81% and improved survival, according to results published in the New England Journal of Medicine A drug used to treat men with late-stage prostate cancer proved effective in stemming …
SLC lodge a place to stay for traveling cancer patients
By: Kevin Jenkins From: thespectrum.com St. George resident Tosha Stevenson knows the challenges of parenting a cancer-stricken child. Her 5-year-old daughter Taleah already has undergone two years of chemotherapy treatments in Salt Lake City and is preparing for a bone marrow transplant next week because of a relapse. Stevenson’s mother and mother-in-law have helped her care for her infant twins …
Biotech firm takes cancer fight to startup level
Renay San Miguel, KING From: usatoday.com Medical research institutions may all target the same maladies, but they regularly compete with each other over talent and funding. So how unusual is it for three of the country’s top cancer research facilities to combine their efforts to form a biotech startup company? “It is relatively rare to bring three institutions of that …